loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Cabotegravir NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Cipla Ltd. (1)

02 Glaxo Wellcome Manufacturing Pte. Ltd (1)

filter

01 CABOTEGRAVIR (1)

02 Cabotegravir (1)

filter

01 India (1)

02 United Kingdom (1)

URL Supplier Web Content
CABOTEGRAVIR
POWDER (25kg/25kg)
BULK INGREDIENT
53104-7740
2023-11-16
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Cabotegravir
POWDER (1kg/kg)
BULK INGREDIENT
52482-017
2019-12-23
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1264720-72-0 / Cabotegravir API manufacturers, exporters & distributors?

Cabotegravir manufacturers, exporters & distributors 1

12

PharmaCompass offers a list of Cabotegravir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cabotegravir manufacturer or Cabotegravir supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cabotegravir manufacturer or Cabotegravir supplier.

PharmaCompass also assists you with knowing the Cabotegravir API Price utilized in the formulation of products. Cabotegravir API Price is not always fixed or binding as the Cabotegravir Price is obtained through a variety of data sources. The Cabotegravir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cabotegravir

Synonyms

1051375-10-0, Gsk1265744, Gsk744, Gsk-1265744, Gsk1265744a, S-265744

Cas Number

1264720-72-0

Unique Ingredient Identifier (UNII)

HMH0132Z1Q

About Cabotegravir

Cabotegravir, or GSK1265744, is an HIV-1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, [rilpivirine]. Early research into cabotegravir showed it had lower oral bioavailability than [dolutegravir]. The devlopment of cabotegravir was later developed to create a long acting monthly intramuscular injection. Cabotegravir was granted FDA approval on 21 January 2021.

Cabotegravir Manufacturers

A Cabotegravir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cabotegravir, including repackagers and relabelers. The FDA regulates Cabotegravir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cabotegravir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cabotegravir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cabotegravir Suppliers

A Cabotegravir supplier is an individual or a company that provides Cabotegravir active pharmaceutical ingredient (API) or Cabotegravir finished formulations upon request. The Cabotegravir suppliers may include Cabotegravir API manufacturers, exporters, distributors and traders.

click here to find a list of Cabotegravir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cabotegravir NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cabotegravir as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cabotegravir API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cabotegravir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cabotegravir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cabotegravir NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cabotegravir suppliers with NDC on PharmaCompass.

Cabotegravir Manufacturers | Traders | Suppliers

Cabotegravir Manufacturers, Traders, Suppliers 1
61

We have 2 companies offering Cabotegravir

Get in contact with the supplier of your choice:

  1. Cipla
  2. GSK
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY